CALR and systemic lupus erythematosus: For example, individuals with the compound heterozygous risk alleles HLA-DR2/HLA-DR3 are more likely to have autoantibodies against Ro, La and Sm, irrespective of an SLE diagnosis (Graham et al., 2007).